Researchers evaluated the effects of solriamfetol on driving performance in patients with excessive daytime sleepiness and obstructive sleep apnea.
In order to assess the efficacy and safety of JZP-258, a lower sodium alternative product to sodium oxybate, study authors designed a double-blind, placebo-controlled, randomized withdrawal, multicenter study with an open-label safety extension.
Snoring is associated with increased risk of cerebral events in patients with obstructive sleep apnea and established cardiovascular disease.
Obesity, night eating, parasomnia, sleep talking and drunkenness, and ADHD symptoms are more frequent in children than adults at narcolepsy diagnosis.
The list, titled “Five Things Physicians and Patients Should Question,” was developed by members of the AAP Section on Pediatric Pulmonology and Sleep Medicine.
Patients with obstructive or central sleep apnea experienced improvements in apnea-hypopnea index following treatment with acetazolamide.
Alzheimer disease may causally influence sleep patterns, but these patterns do not have a causal role in the disease.
The use of intensive lifestyle intervention for weight loss in patients with type 2 diabetes has been shown to reduce the overall severity of obstructive sleep apnea.
The burden of both objective and subjective obstructive sleep apnea improved more in patients who received upper airway stimulation compared with those who did not.
The rates of myocardial infarction were found to decline during the COVID-19 pandemic, which also saw increases in sleep duration.
